You have 9 free searches left this month | for more free features.

Pyoderma Gangrenosum

Showing 1 - 25 of 127

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pyoderma Gangrenosum Trial in New York (Spesolimab)

Recruiting
  • Pyoderma Gangrenosum
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 16, 2023

Pyoderma Gangrenosum Trial (Platelet rich plasma therapy)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Platelet rich plasma therapy
  • (no location specified)
Aug 2, 2023

Pyoderma Gangrenosum Trial (IFX-1, Placebo)

Not yet recruiting
  • Pyoderma Gangrenosum
  • (no location specified)
Jul 28, 2023

Pyoderma Gangrenosum Trial in Lebanon (Deucravacitinib)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Apr 6, 2023

Pyoderma Gangrenosum Trial (Hyperbaric oxygen, Control group)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Hyperbaric oxygen
  • Control group
  • (no location specified)
Jul 14, 2022

Pyoderma Gangrenosum Trial in Gahanna (Ixekizumab)

Completed
  • Pyoderma Gangrenosum
  • Ixekizumab
  • Gahanna, Ohio
    The Ohio State University Dermatology
May 11, 2022

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Not yet recruiting
  • Pyoderma Gangrenosum
  • +2 more
  • immunohistochemical methods
  • (no location specified)
Mar 21, 2022

Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

Active, not recruiting
  • Pyoderma
  • +3 more
  • Monoclonal antibody (Mab) sB24M
  • Minsk, Belarus
  • +1 more
Jul 8, 2022

Pyoderma Gangrenosum Trial in Stanford (Humira)

Withdrawn
  • Pyoderma Gangrenosum
  • Stanford, California
    Stanford University
Feb 3, 2022

Pyoderma Gangrenosum Trial in Metairie, New Orleans (Dehydrated human amnion/chorion membrane)

Recruiting
  • Pyoderma Gangrenosum
  • Dehydrated human amnion/chorion membrane
  • Metairie, Louisiana
  • +2 more
Nov 9, 2021

Pyoderma Gangrenosum, Skin Diseases, Wound Heal Trial in Portland (Baricitinib)

Recruiting
  • Pyoderma Gangrenosum
  • +4 more
  • Portland, Oregon
    Oregon Health and Science University
Sep 8, 2021

Pyoderma Gangrenosum Trial (secukinumab 150 mg (2 injections per dose)

Withdrawn
  • Pyoderma Gangrenosum
  • secukinumab 150 mg (2 injections per dose
  • (no location specified)
May 25, 2021

Disease State in Adult Participants Being Treated With Humira in

Recruiting
  • Pyoderma Gangrenosum
    • Nagoya shi, Aichi, Japan
    • +44 more
    Jan 13, 2023

    Pyoderma Gangrenosum Trial in Tallahassee (Xilonix)

    Completed
    • Pyoderma Gangrenosum
    • Xilonix
    • Tallahassee, Florida
      XBiotech Investigative Site
    Jan 26, 2021

    Pyoderma Gangrenosum Trial in Japan (adalimumab)

    Completed
    • Pyoderma Gangrenosum
    • Nagoya-shi, Aichi, Japan
    • +19 more
    Mar 5, 2021

    Pyoderma Gangrenosum Trial in Munich (Secukinumab)

    Unknown status
    • Pyoderma Gangrenosum
    • Munich, Germany
      Technical University of Munich
    Feb 17, 2020

    Pyoderma Gangrenosum Trial in Winston-Salem (adalimumab)

    Withdrawn
    • Pyoderma Gangrenosum
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences Dermatology
    Dec 17, 2019

    Inflammatory Marker in Ibd and Peripheral Arthritis

    Not yet recruiting
    • IBD-Inflammatory Bowel Disease
      • (no location specified)
      Jan 20, 2023

      Ulcerative Colitis, Crohn Disease Trial in Surat (Vedolizumab IV)

      Active, not recruiting
      • Ulcerative Colitis
      • Crohn Disease
      • Vedolizumab IV
      • Guntur, Andhra Pradesh, India
      • +17 more
      Jan 26, 2023

      Cutaneous Diphtheria in France : Observational, Retrospective

      Not yet recruiting
      • Corynebacterium Diphtheriae Infection
      • Characteristics description
      • Toulon, VAR, France
        HIA Sainte Anne
      Apr 3, 2023

      Comorbidities and Pathologies Associated With Pyoderma

      Unknown status
      • Pyoderma Gangrenosum
      • pathology associated
      • Marseille, Paca, France
        Assistance Publique Des Hopitaux de Marseille
      Aug 17, 2018

      Crohn Disease, Nutrient; Excess, Remission/Regression Trial in Duzce (EEN (Nestle Modulen®), Standart of care)

      Recruiting
      • Crohn Disease
      • +2 more
      • EEN (Nestle Modulen®)
      • Standart of care
      • Duzce, Turkey
        Duzce University School of Medicine
      Oct 15, 2022

      Crohn Disease, Ulcerative Colitis Trial in Tel Aviv (Physical exercises)

      Recruiting
      • Crohn Disease
      • Ulcerative Colitis
      • Physical exercises
      • Tel Aviv, Israel
        Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
      Jan 30, 2022

      Crohn's Disease Trial in Lucknow (Artesunate, Curcumin, Placebo A)

      Not yet recruiting
      • Crohn's Disease
      • Lucknow, Uttar Pradesh, India
        Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIM
      Jan 20, 2021